The US Department of Agriculture approved the genetically modified purple tomato to extend its shelf life and boost nutritional quality almost 15 years after its development.
According to biochemist Cathie Martin, she and her colleagues at Norfolk Plant Scientists (NPS) have been experimenting with pigment production in flowering plants for over two decades, and they've spent almost 15 months developing the purple tomato.
The NPS has been focusing on anthocyanins, the antioxidant-rich pigments that give blackberries and blueberries their signature shades.
Domesticated tomatoes already have genes to produce anthocyanins, but they are not 'turned on.' By carefully adding two genes, the tomatoes and juice become a rich source of antioxidants, because purple pigments are made in the whole tomato, not just the skins.
While there are already some purple-skinned tomatoes, their pigments mostly stop at the outer layers and don't accumulate in the fruit itself.
The NPS also emphasized that there is increasing evidence to show that antioxidants work much better when consumed within foods.
The USDA Animal and Plant Health Inspection Service (APHIS) reported that the tomato was modified to alter its color and enhance its nutritional quality, adding that the plant is unlikely to pose an increased plant pest risk compared to other cultivated tomatoes.
Nathan Pumplin, the CEO of NPS' US-based commercial business, said they are optimistic that they can begin limited distribution of purple tomatoes in the US by 2023.


Climate Adaptation at Home: How Irrigreen Makes Conservation Effortless
Wall Street Slips as Tech Stocks Slide on AI Spending Fears and Earnings Concerns
Sanofi Reports Positive Late-Stage Results for Amlitelimab in Eczema Treatment
Trump Administration to Launch Autism Initiatives Targeting Acetaminophen Use and New Treatment Options
Apple Forecasts Strong Revenue Growth as iPhone Demand Surges in China and India
China Factory Activity Slips in January as Weak Demand Weighs on Growth Outlook
Lost in space: MethaneSat failed just as NZ was to take over mission control – here’s what we need to know now
Trump Threatens 50% Tariff on Canadian Aircraft Amid Escalating U.S.-Canada Trade Dispute
Canada’s Trade Deficit Jumps in November as Exports Slide and Firms Diversify Away From U.S.
Copper Prices Hit Record Highs as Metals Rally Gains Momentum on Geopolitical Tensions
Apple Faces Margin Pressure as Memory Chip Prices Surge Amid AI Boom
U.S. and Rwanda Sign $228 Million Health Partnership to Boost Self-Reliance
CSPC Pharma and AstraZeneca Forge Multibillion-Dollar Partnership to Develop Long-Acting Peptide Drugs
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Is space worth the cost? Accounting experts say its value can’t be found in spreadsheets
Trump Signs Executive Order to Boost AI Research in Childhood Cancer 



